Literature DB >> 28829730

Clinical Characteristics of Severe Japanese Encephalitis: A Case Series from South Korea.

Jun-Sang Sunwoo1, Soon-Tae Lee2,3, Keun-Hwa Jung2,3, Kyung-Il Park4, Jangsup Moon2,3, Ki-Young Jung2,3, Manho Kim5,2,3, Sang Kun Lee2,3, Kon Chu3,2.   

Abstract

Japanese encephalitis (JE) virus is a major cause of devastating viral encephalitis, especially in Asia. Although a successful vaccination program led to its near-elimination over three decades in South Korea, the incidence of JE has increased since 2010. The present study investigated the clinical manifestations, laboratory findings, and factors affecting neurological outcomes of reemerging JE. We retrospectively reviewed medical records of laboratory-confirmed JE patients who presented with acute encephalitis syndrome at three tertiary hospitals between 2010 and 2015. A total of 17 patients with JE were identified. Their median age was 51 years, and 10 (58.5%) were men. The most common symptoms and signs were fever (94.1%), altered consciousness (94.1%), and headache (80.2%). Hyporeflexia (47.1%), seizures (35.2%), abnormal brainstem reflex (23.5%), and flaccid weakness (17.6%) were also noted. Brain imaging revealed thalamic lesions in all patients, with the hippocampus, midbrain, basal ganglia, and cerebral cortex affected to varying degrees. Sixteen patients (94.1%) required management in the intensive care unit with mechanical ventilation due to neurological deterioration. At the time of discharge, 11 (64.7%) had poor recovery, defined as Glasgow coma scale scores of less than 8, and remained ventilator dependent. Comparison between the two outcome groups indicated that midbrain involvement (P = 0.028) and rapid deterioration (P = 0.005) were associated with severe neurological sequelae. Given that JE is a vaccine-preventable disease, vaccination for adults should be considered in response to the reemergence of JE.

Entities:  

Mesh:

Year:  2017        PMID: 28829730      PMCID: PMC5544099          DOI: 10.4269/ajtmh.17-0054

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  38 in total

1.  Comparison of CT scan and MRI findings in the diagnosis of Japanese encephalitis.

Authors:  J Kalita; U K Misra
Journal:  J Neurol Sci       Date:  2000-03-01       Impact factor: 3.181

Review 2.  Japanese encephalitis: surveillance and elimination effort in Japan from 1982 to 2004.

Authors:  Satoru Arai; Yasuko Matsunaga; Tomohiko Takasaki; Keiko Tanaka-Taya; Kiyosu Taniguchi; Nobuhiko Okabe; Ichiro Kurane
Journal:  Jpn J Infect Dis       Date:  2008-09       Impact factor: 1.362

3.  Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis.

Authors:  S K Handique; R R Das; K Barman; N Medhi; B Saharia; P Saikia; S A Ahmed
Journal:  AJNR Am J Neuroradiol       Date:  2006-05       Impact factor: 3.825

4.  Seizures in Japanese encephalitis.

Authors:  U K Misra; J Kalita
Journal:  J Neurol Sci       Date:  2001-09-15       Impact factor: 3.181

5.  Seizures and raised intracranial pressure in Vietnamese patients with Japanese encephalitis.

Authors:  Tom Solomon; Nguyen Minh Dung; Rachel Kneen; Le Thi Thu Thao; Mary Gainsborough; Ananda Nisalak; Nicholas P J Day; Fenella J Kirkham; David W Vaughn; Shelagh Smith; Nicholas J White
Journal:  Brain       Date:  2002-05       Impact factor: 13.501

6.  Japanese encephalitis immunization in South Korea: past, present, and future.

Authors:  Y M Sohn
Journal:  Emerg Infect Dis       Date:  2000 Jan-Feb       Impact factor: 6.883

Review 7.  Infectious causes of acute flaccid paralysis.

Authors:  Tom Solomon; Hugh Willison
Journal:  Curr Opin Infect Dis       Date:  2003-10       Impact factor: 4.915

Review 8.  Japanese encephalitis virus infection.

Authors:  Michael J Griffiths; Lance Turtle; Tom Solomon
Journal:  Handb Clin Neurol       Date:  2014

9.  Clinical profile and outcome of Japanese encephalitis in children admitted with acute encephalitis syndrome.

Authors:  Gitali Kakoti; Prafulla Dutta; Bishnu Ram Das; Jani Borah; Jagadish Mahanta
Journal:  Biomed Res Int       Date:  2013-12-29       Impact factor: 3.411

10.  Prevalence of Neutralizing Antibodies to Japanese Encephalitis Virus among High-Risk Age Groups in South Korea, 2010.

Authors:  Eun Ju Lee; Go-Woon Cha; Young Ran Ju; Myung Guk Han; Won-Ja Lee; Young Eui Jeong
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

View more
  4 in total

1.  Estimates of Japanese Encephalitis mortality and morbidity: A systematic review and modeling analysis.

Authors:  Yuwei Cheng; Nhat Tran Minh; Quan Tran Minh; Shreya Khandelwal; Hannah E Clapham
Journal:  PLoS Negl Trop Dis       Date:  2022-05-25

2.  Myelitis with flaccid paralysis due to Japanese encephalitis: case report and review of the literature.

Authors:  Steven Grewe; Michael Gliem; Daniel B Abrar; Torsten Feldt; Lars Wojtecki; Victor Tan; Shazia Afzal; Sven G Meuth; Tom Luedde; Hans Martin Orth
Journal:  Infection       Date:  2022-04-09       Impact factor: 3.553

3.  Mortality and Disability Due to Japanese Encephalitis in Elderly Adults: Evidence From an Adult Tertiary Care Center in West China.

Authors:  Weixi Xiong; Lu Lu; Yingfeng Xiao; Jinmei Li; Dong Zhou
Journal:  Front Neurol       Date:  2019-08-22       Impact factor: 4.003

4.  Long-term neurological and healthcare burden of adults with Japanese encephalitis: A nationwide study 2000-2015.

Authors:  Hsuan-Ying Chen; Chen-Yi Yang; Cheng-Yang Hsieh; Chun-Yin Yeh; Chang-Chun Chen; Yen-Chin Chen; Chung-Chih Lai; Rebecca Claire Harris; Huang-Tz Ou; Nai-Ying Ko; Wen-Chien Ko
Journal:  PLoS Negl Trop Dis       Date:  2021-09-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.